Journal article
Amplified delivery of indium-111 to EGFR-positive human breast cancer cells.
- Abstract:
-
A method is described to amplify the delivery of 111In to human breast cancer cells utilizing a novel human serum albumin-human EGF (HSA-hEGF) bioconjugate substituted preferentially in the HSA domain with multiple DTPA metal chelators for 111In. 111In-DTPA-HSA-hEGF exhibited a lower receptor-binding affinity than 111In-DTPA-hEGF but was rapidly and specifically bound, internalized and translocated to the nucleus in EGFR-positive MDA-MB-468 breast cancer cells. 111In-DTPA-HSA-hEGF was cytotox...
Expand abstract
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Journal:
- Nuclear medicine and biology More from this journal
- Volume:
- 28
- Issue:
- 8
- Pages:
- 895-902
- Publication date:
- 2001-11-01
- DOI:
- EISSN:
-
1872-9614
- ISSN:
-
0969-8051
Item Description
- Language:
-
English
- Keywords:
- Pubs id:
-
pubs:315095
- UUID:
-
uuid:a2eb0f1b-52fb-480d-ab83-0d5fcb231b64
- Local pid:
-
pubs:315095
- Source identifiers:
-
315095
- Deposit date:
-
2012-12-19
Terms of use
- Copyright date:
- 2001
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record